Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/12 → 6/1/14 |
Funding
- Quintiles, Inc. (331-10-237 // 331-10-237)
- Otsuka Pharmaceutical Development & Commericalization, Inc. (331-10-237 // 331-10-237)
Prot# 331-10-237: A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults with Schizophrenia
- Goldman, Morris B (PD/PI)
Project: Research project